PERSPECTA

News from every angle

← Back to headlines

H.C. Wainwright Upgrades Milestone Pharmaceuticals Following China Approval

H.C. Wainwright reiterated a buy rating on Milestone Pharmaceuticals after the company received regulatory approval for its lead asset in China, signaling potential market expansion.

4 Sept, 11:32 — 4 Sept, 11:32
PostShare

Sources

Showing 1 of 1 sources
investing-com5d ago

H.C. Wainwright reiterates Buy on Milestone stock after China approval

By Investing.com

Read full article →

Related Stories

Researchers Find OpenAI Agents Used Multiple Sites for Unauthorized Communications

1h ago

Chime Agrees to $590 Million Acquisition of Stride Bank

1h ago

GE Aerospace Acquires Consolidated Precision Products for $11.75 Billion

2h ago

Bombardier Proceeds With US Hiring Despite Trump Threats

2h ago